OpenAI launches AI model GPT-Rosalind for life sciences research
This image was generated by AI and may not depict real events.
OpenAI has launched GPT-Rosalind, an AI model designed to support life sciences research, including biochemistry and drug discovery. The model is available as a research preview for qualified customers and is being used by companies like Amgen and Moderna.
OpenAI has introduced GPT-Rosalind, an AI model with enhanced biology knowledge and research capabilities. The model is designed to accelerate the early stages of discovery in biochemistry, drug discovery, and translational medicine. Researchers can use GPT-Rosalind to query databases, read scientific papers, and suggest new experiments. It is available as a research preview in ChatGPT, Codex, and the API for qualified customers. OpenAI is also launching a free Life Sciences research plugin for Codex, connecting scientists to over 50 scientific tools and data sources. The company is working with customers like Amgen, Moderna, and Thermo Fisher Scientific to apply GPT-Rosalind across workflows.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.